181 related articles for article (PubMed ID: 11416945)
1. Correlation of rCBF (SPECT), CSF tau, and cognitive function in patients with dementia of the Alzheimer's type, other types of dementia, and control subjects.
Tsolaki M; Sakka V; Gerasimou G; Dimacopoulos N; Chatzizisi O; Fountoulakis KN; Kyriazis G; Papanastasiou J; Kazis A
Am J Alzheimers Dis Other Demen; 2001; 16(1):21-31. PubMed ID: 11416945
[TBL] [Abstract][Full Text] [Related]
2. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and APO E4 medial temporal lobe dementias. The Oxford Project to Investigate Memory and Aging.
Jobst KA; Barnetson LP; Shepstone BJ
Int Psychogeriatr; 1997; 9 Suppl 1():191-222; discussion 247-52. PubMed ID: 9447442
[TBL] [Abstract][Full Text] [Related]
3. Effect of linearization correction on statistical parametric mapping (SPM): a 99mTc-HMPAO brain perfusion SPECT study in mild Alzheimer's disease.
Ansar MA; Osaki Y; Kazui H; Oku N; Takasawa M; Kimura Y; Begum NN; Ikejiri Y; Takeda M; Hatazawa J
Ann Nucl Med; 2006 Oct; 20(8):511-7. PubMed ID: 17134017
[TBL] [Abstract][Full Text] [Related]
4. Accurate prediction of histologically confirmed Alzheimer's disease and the differential diagnosis of dementia: the use of NINCDS-ADRDA and DSM-III-R criteria, SPECT, X-ray CT, and Apo E4 in medial temporal lobe dementias. Oxford Project to Investigate Memory and Aging.
Jobst KA; Barnetson LP; Shepstone BJ
Int Psychogeriatr; 1998 Sep; 10(3):271-302. PubMed ID: 9785148
[TBL] [Abstract][Full Text] [Related]
5. A comparison of (99m)Tc-HMPAO SPET changes in dementia with Lewy bodies and Alzheimer's disease using statistical parametric mapping.
Colloby SJ; Fenwick JD; Williams ED; Paling SM; Lobotesis K; Ballard C; McKeith I; O'Brien JT
Eur J Nucl Med Mol Imaging; 2002 May; 29(5):615-22. PubMed ID: 11976799
[TBL] [Abstract][Full Text] [Related]
6. [Molecular neuroimaging in the study of cognitive impairment: contribution of the cerebral blood flow SPECT with 99mTc-HMPAO and 18F-FDG PET/CT scan].
Banzo I; Quirce R; Martínez-Rodríguez I; Jiménez-Bonilla J; Portilla-Quattrociocchi H; Medina-Quiroz P; Ortega F; Rodríguez E; Mateo I; Vázquez-Higuera JL; de Arcocha M; Carril JM
Rev Esp Med Nucl; 2011; 30(5):301-6. PubMed ID: 21640440
[TBL] [Abstract][Full Text] [Related]
7. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
[TBL] [Abstract][Full Text] [Related]
8. Combined magnetic resonance imaging and single-photon emission tomography scanning in the discrimination of Alzheimer's disease from age-matched controls.
O'Brien JT; Ames D; Desmond P; Lichtenstein M; Binns D; Schweitzer I; Davis S; Tress B
Int Psychogeriatr; 2001 Jun; 13(2):149-61. PubMed ID: 11495391
[TBL] [Abstract][Full Text] [Related]
9. [Correlations between brain SPECT and neuropsychology assessments in mild and moderate stages of Alzheimer's disease].
Arbizu J; Larumbe R; Gámez C; Martí J; Martínez-Lage J; Richter J
Rev Esp Med Nucl; 1999 Aug; 18(4):252-60. PubMed ID: 10481106
[TBL] [Abstract][Full Text] [Related]
10. Parametric mapping of cerebral blood flow deficits in Alzheimer's disease: a SPECT study using HMPAO and image standardization technique.
Imran MB; Kawashima R; Awata S; Sato K; Kinomura S; Ono S; Yoshioka S; Sato M; Fukuda H
J Nucl Med; 1999 Feb; 40(2):244-9. PubMed ID: 10025830
[TBL] [Abstract][Full Text] [Related]
11. CSF Alzheimer's disease-like pattern in corticobasal syndrome: evidence for a distinct disorder.
Borroni B; Premi E; Agosti C; Alberici A; Cerini C; Archetti S; Lanari A; Paghera B; Lucchini S; Caimi L; Padovani A
J Neurol Neurosurg Psychiatry; 2011 Aug; 82(8):834-8. PubMed ID: 21345847
[TBL] [Abstract][Full Text] [Related]
12. Memory-provoked rCBF-SPECT as a diagnostic tool in Alzheimer's disease?
Sundström T; Elgh E; Larsson A; Näsman B; Nyberg L; Riklund KA
Eur J Nucl Med Mol Imaging; 2006 Jan; 33(1):73-80. PubMed ID: 16151770
[TBL] [Abstract][Full Text] [Related]
13. 99mTc-HMPAO regional cerebral blood flow and quantitative electroencephalography in Alzheimer's disease: a correlative study.
Rodriguez G; Nobili F; Copello F; Vitali P; Gianelli MV; Taddei G; Catsafados E; Mariani G
J Nucl Med; 1999 Apr; 40(4):522-9. PubMed ID: 10210209
[TBL] [Abstract][Full Text] [Related]
14. Value of neuropsychological testing, imaging, and CSF biomarkers for the differential diagnosis and prognosis of clinically ambiguous dementia.
Boutoleau-Bretonnière C; Lebouvier T; Delaroche O; Lamy E; Evrard C; Charriau T; Bretonnière C; Damier P; Derkinderen P; Vercelletto M
J Alzheimers Dis; 2012; 28(2):323-36. PubMed ID: 22008265
[TBL] [Abstract][Full Text] [Related]
15. SPECT patterns in probable Alzheimer's disease.
Müller H; Möller HJ; Stippel A; Fric M; Grünwald F; Laux G; Klemm E; Biersack HJ
Eur Arch Psychiatry Clin Neurosci; 1999; 249(4):190-6. PubMed ID: 10449594
[TBL] [Abstract][Full Text] [Related]
16. Regional cerebral blood flow measured by 99mTc-HMPAO SPECT differs in subgroups of Alzheimer's disease.
Soininen H; Helkala EL; Kuikka J; Hartikainen P; Lehtovirta M; Riekkinen PJ
J Neural Transm Park Dis Dement Sect; 1995; 9(2-3):95-109. PubMed ID: 8527009
[TBL] [Abstract][Full Text] [Related]
17. CSF total and phosphorylated tau protein, regional glucose metabolism and dementia severity in Alzheimer's disease.
Haense C; Buerger K; Kalbe E; Drzezga A; Teipel SJ; Markiewicz P; Herholz K; Heiss WD; Hampel H
Eur J Neurol; 2008 Nov; 15(11):1155-62. PubMed ID: 18803648
[TBL] [Abstract][Full Text] [Related]
18. Discriminative use of SPECT in frontal lobe-type dementia versus (senile) dementia of the Alzheimer's type.
Pickut BA; Saerens J; Mariën P; Borggreve F; Goeman J; Vandevivere J; Vervaet A; Dierckx R; de Deyn PP
J Nucl Med; 1997 Jun; 38(6):929-34. PubMed ID: 9189144
[TBL] [Abstract][Full Text] [Related]
19. The relationship between the diagnosis method of neuronal dysfunction (DIMENSION) and brain pathology in the early stages of Alzheimer's disease.
Kouzuki M; Asaina F; Taniguchi M; Musha T; Urakami K
Psychogeriatrics; 2013 Jun; 13(2):63-70. PubMed ID: 23909962
[TBL] [Abstract][Full Text] [Related]
20. Differential role of CSF fatty acid binding protein 3, α-synuclein, and Alzheimer's disease core biomarkers in Lewy body disorders and Alzheimer's dementia.
Chiasserini D; Biscetti L; Eusebi P; Salvadori N; Frattini G; Simoni S; De Roeck N; Tambasco N; Stoops E; Vanderstichele H; Engelborghs S; Mollenhauer B; Calabresi P; Parnetti L
Alzheimers Res Ther; 2017 Jul; 9(1):52. PubMed ID: 28750675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
